Skip to main content

Education/ACR/EULAR

      Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020
      4 years 6 months ago
      Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020
      RT @KDAO2011: #EULAR2020 Updated RA Mgmt Recc
      Main points:
      1. MTX 1st line (if contraind, then SSZ/LEF; NOT HCQ)
      2. Add
      4 years 6 months ago
      #EULAR2020 Updated RA Mgmt Recc Main points: 1. MTX 1st line (if contraind, then SSZ/LEF; NOT HCQ) 2. Add bDMARD/JAKi if 1st csDMARD doesn't work + poor Px 3. Use IL-6i or JAKi for pts who can only take monoRx and failed csDMARD @RheumNow https://t.co/AIXz2dEOrX
      RT @uptoTate: Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before
      4 years 6 months ago
      Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before or during pregnancy. Few on TNFi were continued on tx during pregnancy. #EULAR2020 @RheumNow https://t.co/t7B6pASeWQ https://t.co/BwU6RF5Qkn
      RT @uptoTate: Sustained clinical response shown over the 10 yrs of this German study in r-axSpA and nr-axSpA pts treated
      4 years 6 months ago
      Sustained clinical response shown over the 10 yrs of this German study in r-axSpA and nr-axSpA pts treated with ETN. No new safety signals. Abstract #AB0660 #EULAR2020 @RheumNow https://t.co/KCMDyzHaSr https://t.co/yFSTgWqzBQ
      RT @uptoTate: Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 pat
      4 years 6 months ago
      Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 patients within the first 5 months. New-onset MEM is also observed in up to 15% of patients with IBD treated with VDZ. #EULAR2020 @RheumNow https://t.co/ZVjZC7hvxs https://t.co/d1RT3GzB2b
      Study of the French registries for TCZ, RTX, ABA, compared the risk of GI perforations (GIP). GIP risk was higher with
      4 years 6 months ago
      Study of the French registries for TCZ, RTX, ABA, compared the risk of GI perforations (GIP). GIP risk was higher with TCZ (vs RTX,ABA) but was largely due to TCZ increasing the risk of diverticulitis. #EULAR2020 #OP0022 https://t.co/MGGWiVh5Jv https://t.co/nC2NblYnGO
      RT @RheumNow: When starting IV Pegloticase in #Gout, Do you start a DMARD too? #EULAR2020
      4 years 6 months ago
      When starting IV Pegloticase in #Gout, Do you start a DMARD too? #EULAR2020
      RT @KDAO2011: #EULAR2020 Recc for irAEs w/ICI:
      1. GC's ok, goal<10 mg/d, any csDMARD, bDMARD (TNFi/IL-6),🚫ABT xcep
      4 years 6 months ago
      #EULAR2020 Recc for irAEs w/ICI: 1. GC's ok, goal<10 mg/d, any csDMARD, bDMARD (TNFi/IL-6),🚫ABT xcept life-threatening myositis 2. Myositis beware bulbar signs: dysphagia, dysarthria, dysphonia: stop ICIs,⬆️GC, IVIG/PE 3. Don't test autoAbs b/f ICI Rx https://t.co/P5jDgnjK94
      RT @Janetbirdope: Can you classify SLE by labs only but should you? Serology is part of criteria but why dx with only +A
      4 years 6 months ago
      Can you classify SLE by labs only but should you? Serology is part of criteria but why dx with only +ANA, +antiDNA and no other CTD characteristics. Would need cytopenias & RBC casts to think of lab dx of SLE OP0094 @LupusCanada @RheumNow @eular_org #EULAR2020 @CRASCRRheum https://t.co/Jr6SRr3HR1
      Avacopan is as effective as steroids in ANCA Assoc Vasculitis – 330 pt RCT AAV Rx w/ RTX or CTX but randomized to pred
      4 years 6 months ago
      Avacopan is as effective as steroids in ANCA Assoc Vasculitis – 330 pt RCT AAV Rx w/ RTX or CTX but randomized to prednisone or avacopan (C5aR antagonist). Avacopan=prednisone remission rates same (72% vs 70%) wk 26 & wk 52 (66% vs 55%). #EULAR2020 #OP0011 https://t.co/WIXJCYkxSb
      ×